A new approach to Alzheimer’s disease (AD) that may eventually make it possible to reverse memory loss is outlined in newly published research led by Zhen Yan, PhD, SUNY Distinguished Professor of physiology and biophysics.
Cytocybernetics, a UB spinoff founded by two Jacobs School of Medicine and Biomedical Sciences faculty members, has received a $250,000 Small Business Innovation Research award from the National Institute of Mental Health (NIMH) to move into a new market: neuronal drug development.
